HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lessons learned from a lipid lowering trial in adolescents with type 1 diabetes.

Abstract
Herein, we describe recruitment efforts for a trial of lipid-lowering medications in adolescents with type 1 diabetes, age 12-21 years. Based on our experience, future studies will require multiple centers to enroll a sufficient number of participants for adequate data to direct dyslipidemia medication treatment guidelines for adolescents with type 1 diabetes.
AuthorsFranziska K Bishop, R Paul Wadwa, Sam Ellis, Marian Rewers, David M Maahs
JournalInternational journal of pediatric endocrinology (Int J Pediatr Endocrinol) Vol. 2012 Issue 1 Pg. 24 (Jul 30 2012) ISSN: 1687-9856 [Electronic] England
PMID22846167 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: